Skip to content

Effect of surgery on foot function in the management of equinovarus foot deformity following stroke

Effect of surgery on foot function in the management of equinovarus foot deformity following stroke - Equinovarus foot function after stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55426
Enrollment
40
Registered
2016-12-02
Start date
2017-03-30
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral vascular accident (CVA) stroke

Interventions

None listed

Sponsors

Revalidatiecentrum Het Roessingh
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Unilateral ischaemic or haemorrhagic hemiparetic stroke 2. Time since stroke > 6 months 3. Age 18 years or older 4. Walking disabilities and/or fall incidents and/or pressure sores on the foot and/or unable to walk bare foot due to structural or dynamic equinovarus foot deformity, including a. problems with stability in stance b. problems with foot clearance during swing c. problems with foot prepositioning in early stance 5. Subject is selected for surgical correction of equinovarus foot only (so no intervention to structures around knee that may influence gait) 6. Subject is able to participate in an 1.5 hour session, including several stand and walking activities (walking aids allowed) with breaks in-between

Exclusion criteria

Exclusion criteria: 1. Complicating medical history such as cardiac, pulmonary, neurological or orthopaedic disorders that could severely affect performance of the included measurements 2. Neurolysis (fenol/alcohol)

Design outcomes

Primary

MeasureTime frame
The main study parameters includes the effect of surgery on restoring foot and ankle kinematics (motion).

Secondary

MeasureTime frame
Furthermore, the effects of surgery on walking ability such as walking speed and endurance and fall risk, as well as daily participation measures is assessed.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)